Re: 'The impact of systemic psoriasis treatments on human papillomavirus activation and propagation'-What about anal malignancies?

Australasian Journal of DermatologyVolume 64, Issue 2 p. e204-e206 LETTER Re: ‘The impact of systemic psoriasis treatments on human papillomavirus activation and propagation’—What about anal malignancies? James P. Pham MD, Corresponding Author James P. Pham MD [email protected] orcid.org/0000-0002-9263-3889 St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia School of Clinical Medicine, UNSW Medicine and Health, St Vincent's Hospital, Sydney, New South Wales, Australia Correspondence Dr James P. Pham, St Vincent's Hospital Sydney, 390 Victoria St, Darlinghurst, New South Wales, 2010, Australia. Email: [email protected]Search for more papers by this authorRichard J. Hillman MD FRCP FAChSHM, Richard J. Hillman MD FRCP FAChSHM orcid.org/0000-0002-1859-0761 St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia School of Clinical Medicine, UNSW Medicine and Health, St Vincent's Hospital, Sydney, New South Wales, AustraliaSearch for more papers by this authorAnnika Smith MBBS (Hons 1) MPHTM FRACP FACD, Annika Smith MBBS (Hons 1) MPHTM FRACP FACD orcid.org/0000-0001-9520-920X St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, AustraliaSearch for more papers by this author James P. Pham MD, Corresponding Author James P. Pham MD [email protected] orcid.org/0000-0002-9263-3889 St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia School of Clinical Medicine, UNSW Medicine and Health, St Vincent's Hospital, Sydney, New South Wales, Australia Correspondence Dr James P. Pham, St Vincent's Hospital Sydney, 390 Victoria St, Darlinghurst, New South Wales, 2010, Australia. Email: [email protected]Search for more papers by this authorRichard J. Hillman MD FRCP FAChSHM, Richard J. Hillman MD FRCP FAChSHM orcid.org/0000-0002-1859-0761 St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia School of Clinical Medicine, UNSW Medicine and Health, St Vincent's Hospital, Sydney, New South Wales, AustraliaSearch for more papers by this authorAnnika Smith MBBS (Hons 1) MPHTM FRACP FACD, Annika Smith MBBS (Hons 1) MPHTM FRACP FACD orcid.org/0000-0001-9520-920X St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, AustraliaSearch for more papers by this author First published: 20 February 2023 https://doi.org/10.1111/ajd.14009Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Korecka K, Wiśniewska-Szymańska A, Mikiel D. The impact of systemic psoriasis treatments on human papillomavirus activation and propagation. Australas J Dermatol. 2022; 63(3): 293–302. 2Siddharthan RV, Lanciault C, Tsikitis VL. Anal intraepithelial neoplasia: diagnosis, screening, and treatment. Ann Gastroenterol. 2019; 32(3): 257–63. 3Clifford GM, Georges D, Shiels MS, Engels EA, Albuquerque A, Poynten IM, et al. A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale. Int J Cancer. 2021; 148(1): 38–47. 4Kirkpatrick A, Bidwell J, van den Brule AJC, Meijer CJLM, Pawade J, Glew S. TNFα polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol. 2004; 92(2): 675–9. 5Biancone L, Orlando A, Kohn A, Colombo E, Sostegni R, Angelucci E, et al. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. Gut. 2006; 55(2): 228–33. 6Walch-Rückheim B, Mavrova R, Henning M, Vicinus B, Kim YJ, Bohle RM, et al. Stromal fibroblasts induce CCL20 through IL6/C/EBPβ to support the recruitment of Th17 cells during cervical cancer progression. Cancer Res. 2015; 75(24): 5248–59. 7Brunet-Possenti F, Charpentier C, Collin G, Descamps D, Descamps V. Impact of anti-interleukin-17 treatment on cutaneous and genital human papillomavirus infection. Br J Dermatol. 2018; 179(5): 1179–80. 8Rosales BM, Langton-Lockton J, Cornall AM, Roberts JM, Hillman RJ, Webster AC. Transplant recipients and anal neoplasia study: design, methods, and participant characteristics of a prevalence study. Transplant Direct. 2019; 5(4):e434. 9Jin F, Grulich AE, Poynten IM, Hillman RJ, Templeton DJ, Law CL, et al. The performance of anal cytology as a screening test for anal HSILs in homosexual men. Cancer Cytopathol. 2016; 124(6): 415–24. 10Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol. 2011; 119(1): 5–19. 11Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA, et al. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. N Engl J Med. 2022; 386(24): 2273–82. 12Palefsky JM, Giuliano AR, Goldstone S, Moreira ED Jr, Aranda C, Jessen H, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011; 365(17): 1576–85. 13Lichter K, Krause D, Xu J, Tsai SHL, Hage C, Weston E, et al. Adjuvant human papillomavirus vaccine to reduce recurrent cervical dysplasia in unvaccinated women: a systematic review and meta-analysis. Obstetr Gynecol. 2020; 135(5): 1070–83. 14Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ. SEER survival monograph: cancer survival among adults: US SEER program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program, NIH Pub 2007;7(6215):193–202. Volume64, Issue2May 2023Pages e204-e206 ReferencesRelatedInformation